title: Update on invasive fungal disease.
abstract: One of the highlights of the antifungal sessions at the ECCMID-ICC congress was the presentation of the first European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline for diagnostic and management for Candida diseases. Experts also discussed specific aspects of the management of invasive fungal disease in the intensive care unit and in hematological malignancy. Data from new clinical studies and from 'real life' experience of clinical use of antifungal therapy were also presented and discussed.
authors.affiliation: Instituto di Ematologica, Università Cattolica del Sacro Cuore, Largo Francesco Vita, 1, I-00168, Rome, Italy. lpagano@rm.unicatt.it
authors.forename: Livio
authors.initials: L
authors.lastname: Pagano
authors.forename: Joanna
authors.initials: J
authors.lastname: Lumb
mesh_terms: D000818:Animals; D019072:Antibiotic Prophylaxis; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects*; D058365:Candidiasis, Invasive / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D003422:Critical Care; D025141:Drug Resistance, Fungal; D005060:Europe; D019337:Hematologic Neoplasms / Q000150:complications; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D000935:Antifungal Agents